Post-mortem studies have demonstrated that UPR activation occurs throughout the brain in these diseases including PSP, PD, ALS, and FTD variants with tau pathology [17, 22, 32, 43]. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.